Evogliptin Impurity S2
 
		Product Description
CAT No.
				
									ALN-E047003								
				CAS No.
				
									NA								
				Mol. F.
				
									C19H26F3N3O3 : C4H6O6								
				Mol. Wt.
				
									401.4 : 150.1								
				Stock
				
									Please Inquire								
				
										
							
										Product Overview
						
											
										
							
										Technical Data
						
											
										
							
										Reference
						
											
										
							
										RFQ
						
									
							
							
							Product Overview
			
						
									Chemical Name : (R)-4-((S)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(tert-butoxymethyl)piperazin-2-one (2R,3R)-2,3-dihydroxysuccinate								
				
									Smiles : O[C@H]([C@H](C(O)=O)O)C(O)=O.O=C1NCCN(C(C[C@@H](N)CC2=CC(F)=C(F)C=C2F)=O)[C@@H]1COC(C)(C)C								
				
									Inchi : InChI=1S/C19H26F3N3O3.C4H6O6/c1-19(2,3)28-10-16-18(27)24-4-5-25(16)17(26)8-12(23)6-11-7-14(21)15(22)9-13(11)20;5-1(3(7)8)2(6)4(9)10/h7,9,12,16H,4-6,8,10,23H2,1-3H3,(H,24,27);1-2,5-6H,(H,7,8)(H,9,10)/t12-,16-;1-,2-/m01/s1								
				
							
							
							Technical Data
			
						
							
							
							Reference
			
						Beneficial Effects of Evogliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, on Adiposity with Increased Ppargc1a in White Adipose Tissue in Obese Mice
									Yu-Na Chae, Tae-Hyoung Kim, Mi-Kyung Kim, Chang-Yell Shin, Il-Hoon Jung, Yong Sung Sohn, and Moon-Ho SonnPLoS One. 2015; 10(12): e0144064.								
				
							
							
							RFQ
			
						
 
                             
                             
                             
                             
                            